跳至主要内容
临床试验/CTRI/2025/08/092162
CTRI/2025/08/092162尚未招募不适用

A Randomized Single Blind Placebo Controlled Study to Assess the Therapeutic Efficacy of Rosmarinus Officinalis 30 in the Management of Telogen Effluvium in Females

Swasthya Kalyan Homoeopathic Medical College and Research Centre1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2025年8月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
90
试验地点
1
主要终点
Assessment done on pre and post score by using Alopecia Scoring Scale and regular follow up

研究概览

简要总结

This study is a sincere attempt to study the role of Rosmarinus officinalis in the management of Telogen Effluvium in Females. The results may provide valuable insights into an effective non invasive approach to hair loss management and potentially broaden treatment options in homeopathy. This study will assess whether Rosmarinus officinalis significantly reduces hair shedding in females with Telogen Effluvium using Alopecia Scoring Scale and study will also identify the most common etiological factors responsible for Telogen Effluvium using Hair Loss Questionnaire and evaluate the action of Rosmarinus officinalis against those factors. The study will be done for 1 year on total 90 patients of Telogen Effluvium.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Participant Blinded

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
Female

入选标准

  • 1 New and Pre Diagnosed cases of Telogen Effluvium 2 Females between age group 18 to 60 years 3 Patients with history of hair fall after Physiological stress like Febrile Illness ,Surgeries ,Infection ,Childbirth but medicine will be given only when she has completely stopped breast feeding 4 Patients who are not taking any medication or those who are taking other modes or allopathic treatment and ready to stop their treatment are included.
  • 5 Patients who are ready to give written consent.

排除标准

  • 1 Pregnant women and lactating mothers will not be included in the study 2 Patients suffering from any systemic illness for example Cancer, Autoimmune diseases, Hyperthyroidism, Hypothyroidism ,Renal disease ,Liver disease or any advance pathology 3 Individuals with scalp-specific dermatological conditions such as psoriasis or seborrheic dermatitis.

结局指标

主要结局

Assessment done on pre and post score by using Alopecia Scoring Scale and regular follow up

时间窗: 12 months

次要结局

  • This study will identify the most common etiological factors responsible for Telogen Effluvium and evaluate the action of Rosmarinus officinalis against those factors(12 months)

研究者

发起方
Swasthya Kalyan Homoeopathic Medical College and Research Centre
申办方类型
Research institution and hospital
责任方
Principal Investigator
主要研究者

Kirti Rinwa

Swasthya Kalyan Homoeopathic Medical College and Research Centre

研究点 (1)

Loading locations...

相似试验